1.dr.haerani rasyid-simposium prinsip terapi nutrisi dialisis
DESCRIPTION
dialisisTRANSCRIPT
PRINSIP TERAPI NUTRISI PASIEN DIALISISPRINSIP TERAPI NUTRISI PASIEN DIALISIS
Haerani RasyidHaerani Rasyid
Sub Divisi Ginjal HiprtensiDepartemen Ilmu Penyakit Dalam
FK UNHAS2015
Sub Divisi Ginjal HiprtensiDepartemen Ilmu Penyakit Dalam
FK UNHAS2015
PendahuluanPendahuluan
Status nutrisi individu dipengaruhi oleh berbagai faktorStatus nutrisi individu dipengaruhi oleh berbagai faktor
-- Intake makananIntake makanan-- Intake makananIntake makanan
-- JJumlah dan kualitas makananumlah dan kualitas makanan
-- Kondisi individuKondisi individu
Tujuan penilaian nutrisi- Status fxonal, intake makanan dan komposisi
tubuh (refleksikan kalori dan protein )- Memprediksi morbiditas dan mortalitas
Bagaimana dengan pasienDialisis??
- Memprediksi morbiditas dan mortalitas- Memprediksi lama tinggal/biaya di RS
Memperbaikiasupan makan
Dukungan nutrisi untukperbaikan metabolik
Mencegah PEWMeningkatkan Tujuan Mencegah PEW
Mencapai danmempertahankan status gizi
baik
Meningkatkanpengetahuan gizi
TujuanTatalaksana Gizi
Faktor-faktor yang mempengaruhi gangguan status nutrisipasien PGK non-D / PGK - D
Condition Mechanism
Anorexia Inadequate protein or calorieintake
Metabolic acidosis Stimulation of amino acid andprotein degradation
Infection/inflamatory illness Stimulation of proteindegradation
Diabetes Stimulation of proteindegradation and suppressionof protein synthesis
Pre-ESRD
+
Profil nutrisiProfil nutrisi pasienpasien CKDCKD
Transplant*
++
Dialysis
++
Transplant
+/-1. Malnourished
(Undernutrition)
++ ++
* first 3 months
++2. Obese
Protein Energy Wasting’ (PEW)
(An expert panel from the International Society ofRenal Nutrition and Metabolism proposed the term
‘protein energy wasting’ (PEW) to designatemalnutrition in kidney diseases)
Protein Energy Wasting’ (PEW)Malnutrisi Penyakit Ginjal
Kronik
NDT Plus (20 ) 3: 118–124
Wasting bukan hanyadisebabkan oleh asupan zat gizi
The International Society of RenalNutrition and Metabolism (2013)
disebabkan oleh asupan zat giziyang inadekuat atau meningkatnya
kehilangan zat gizi
Kovesdy CP, Kopple JD, KalantarKovesdy CP, Kopple JD, Kalantar--Zadeh K. Management of proteinZadeh K. Management of protein--energy wasting in nonenergy wasting in non--dialysisdialysisdependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clindependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin
Nutr 2013;97:1163Nutr 2013;97:1163--7777
„Type II“
2 tipe malnutrisi / PEW
„Type I“
„uremic“ malnutrition/wasting
Pupim L, Ikizler TA: Uremic malnutrition: New insights into old problem.Semin Dial 2003; 16: 224-232
Perbedaan tipe Malnutrisi / PEW pasien CKD
Factors Type 1 Type 2
Associated with uremicsyndrome
Associated with MIAsyndrome
Serum AlbuminComorbidityPresence of inflamation
Normal/lowUncommon
No
LowCommon
YesFood intakeResting energyexpenditureOxidative catabolismReversed by dialysis andnutritional support
DecreasedNormal
IncreasedDecreased
Yes
Low/NormalElevated
Markedly IncreasedIncreased
No
Clinical Queries : Nephrology I (2012) ; 222-235
Kriteria Diagnostik PEWSuggested by the PEW Consensus Conferences
PRIMARY CRITERIA
1. Biochemical markersAlbumin < 3.8g/dl (BCG)Prealbumin (transthyretin) < 30mg/dl (dyalisis pts)Total cholesterol < 100mg/dl
2. Body composition indicesBody Mass Index <22 kg/m2 (<65 years) or <23 kg/m2(>65 years)Unintentional weight loss > 5% over 3 mo or 10% over 6mo
SUPORTIVE CRITERIA
1.Appetite,food intake, and energy expenditureAppetite assessmentFood frequency questionnaires2. Body Mass and compositionTotal body nitrogen or potassiumEnergy-beam based methodsDual-emmision X-ray absorptiometryBioelectric Impedance AnalysisNear Infrared Reactancemo
Total body fat percentage < 10%3. Muscle mass
Muscle wasting 5% over 3 mo or 10% over 6 moReduced mid-arm muscle circumference areaCreatinin appearence
4. Dietary intakeUnintentional dietary protein intake (DPI) < 0,80g/kg/day(Evidence indicates that ≤ 1.0 g protein/kg/day mayengender protein wasting in some patients)Unintentional dietary energy intake (DEI) < 25Kcal/kg/day(Data indicate that some patient may need ≥ 30 kg/day)
Near Infrared Reactance3.Other laboratory biomarkersSerum biochemistry : transferin, urea, triglyceride,bicarbonateHormones : leptin, ghrelin, growth hormonesInflammatory markers : CRP,IL-6, TNF-α, IL-1β,SAAPeripheral blood cell count lymphocyte count or percentage4.Nutritional scoring systemsSubjective Global AssessmentMalnutrition-Inflation Sore (MIS )5.Other novel markers14kD Actin fragment [82,97]Gelsoiln [98]
Nutritional Management of Renal Disease
http://dx.doi.org/10.1016/B978-0-12-391934-2.00011-4
Penyakit Ginjal KronikPenyakit Ginjal Kronik
Laju Filtrasi GlomerulusLaju Filtrasi Glomerulus
Konsentrasi solut meningkatKonsentrasi solut meningkat
(urea, kreatinin, fosfat, sulfat, as. urat, H(urea, kreatinin, fosfat, sulfat, as. urat, H++,,fenol,guanidin, as. organik, indol, mioinositol,fenol,guanidin, as. organik, indol, mioinositol,
poliamin,poliamin, 22--mikroglobulin, Al, Zn, Cu, Fe)mikroglobulin, Al, Zn, Cu, Fe)
Gangguan metabolisme tubuhGangguan metabolisme tubuh
Gangguan metabolisme glukosaGangguan metabolisme glukosaGangguan metabolisme lipidGangguan metabolisme lipid
Gangguan metabolisme proteinGangguan metabolisme protein
Pasien hemodialisisPasien hemodialisis
Gangguan metabolisme proteinGangguan metabolisme proteinGangguan metabolisme asam aminoGangguan metabolisme asam amino
GangguanGangguan metabolismemetabolisme glukosaglukosaResistensiResistensi InsulinInsulin
HipoglikemiaHipoglikemia
GangguanGangguan metabolismemetabolisme lipidlipidAbnormalitas utama lipid sirkulasi
Kwan BCH; Kronenberg F, Beddhu S, and Cheung AK: Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol 18: 1246-1261, 2007
Terjadi peningkatanTerjadi peningkatan turnoverturnover protein ototprotein ototdan protein di seluruh tubuhdan protein di seluruh tubuh
Penyebab kehilanganPenyebab kehilangan lean body masslean body masspasien HD:pasien HD:
Gangguan Metabolisme Protein
Inflamasi meningkatkan katabolismeInflamasi meningkatkan katabolismeproteinprotein
Inflamasi sistemik terjadi (50% pasien)Inflamasi sistemik terjadi (50% pasien)
Penyebab sindroma inflamasi pasien HDPenyebab sindroma inflamasi pasien HDkronik :kronik :
oxidation inoxidation inmusclesmuscles
BCAABCAAvalinevalineleucineleucineisoleucineisoleucine
threoninethreoninelysinelysineserineserine
Essential AAEssential AANonNon--essential AAessential AASpecial AASpecial AA
GangguanGangguan metabolismemetabolisme AsamAsam aminoamino
NORMALNORMALKIDNEYKIDNEY
phenylalaninephenylalaninehydroxylationhydroxylation
tyrosinetyrosine
tryptophanetryptophane
protein bindingprotein bindingarginine ↓arginine ↓
glycineglycine
citrulinecitrulinecystinecystineaspartateaspartatemethioninemethioninemethylmethyl--histidinehistidine Mitch WE. Handbook of Nutrition and the Kidney, 2003
oxidation inoxidation inmusclesmuscles
BCAA↓BCAA↓valine ↓ ↓valine ↓ ↓leucine ↓leucine ↓isoleucine ↓isoleucine ↓
threonine ↓threonine ↓lysine ↓lysine ↓serine ↓serine ↓
decreasedecreaseproductionproduction
Essential AAEssential AANonNon--essential AAessential AASpecial AASpecial AA
KIDNEYKIDNEYFAILUREFAILURE
metabolicmetabolicacidosisacidosis
defectivedefectivephenylalaninephenylalaninehydroxylationhydroxylation
tyrosine ↓tyrosine ↓
tryptophane ↓tryptophane ↓
reducereduceprotein bindingprotein bindingarginine ↓arginine ↓
glycine ↑glycine ↑citruline ↑citruline ↑cystinecystine ↑↑aspartate ↑aspartate ↑methionine ↑methionine ↑methylmethyl--histidinehistidine ↑↑ Mitch WE. Handbook of Nutrition and the Kidney, 2003
Amino AcidAmino Acid typetype changeschanges
ValineValine EE ↓↓ ↓↓LeucineLeucine EE ↓↓IsoIso--leucineleucine EE ↓↓
ThreonineThreonine EE ↓↓LysineLysine EE ↓↓SerineSerine NENE ↓↓
Abnormalitas asam amino pasien PGK-HD
TyrosineTyrosine spEspE ↓↓TryptophaneTryptophane EE ↓↓
GlycineGlycine NENE ↑↑AspartateAspartate NENE ↑ ↑ MethionineMethionine EE ↑↑MethylMethyl--HistidineHistidine spAAspAA ↑↑
Rekomendasi asupan protein dan energi pasien HD kronikRekomendasi asupan protein dan energi pasien HD kronik
Kebutuhan mineral pasien HD kronik
SGA or MIS
Alur dukungan nutrisi pasien HD PEWAlur dukungan nutrisi pasien HD PEW
indikasi
Kontra indikasi
dosis
Cara pemberian
oral
MonitoringESPEN Guidelines on Parenteral Nutrition. Clin Nutr 2009
Pasien CAPDPasien CAPD
Nutritional status of PD and HDpatients
PD HD
Total 51 169
Well-nourished 34 (67%) 139 (82%)
• Asupan makantidak cukup
• Metabolisme zatgizi abnormal
Mildlymalnourished
8 (15%) 24 (14%)
Moderatelymalnourished
7 (14%) 6 (4%)
Severelymalnourished
2 (4%) 0
33% of PD patients were malnourished compared to 18% of HD patients.
Park YK et al, J Ren Nutr 1999; 9: 149-56
gizi abnormal
• Inflamasi
• Abnormalitashormonal
• Cepat kenyang dan perutterasa penuh
• Waktu pengosongan lambunglambat karena dialisatmenyebabkan aktivitaselektrik lambung abnormal
• Distensi abdomen akbat
• Nyeri abdomen, konstipasi,diare, stool urgency
• Distensi abdomen akbatdialisat
• Peningkatan leptin
Pola danNafsu Makan
Gejala GI
• Kehilangan PD > HD• Peritonitis >> 15-
100 g/hari• Loss terutama
albumin dan
• Cairan dialisatmengandung glukosa
• Agen osmotik• Absorpsi sekitar 100 – 200
g glukosa per hari (20%asupan energi total)
• Absorpsi glukosa dapatalbumin danimmunoglobulin
Kehilanganprotein
• Absorpsi glukosa dapatdiestimasikan sebagaikalori yang diabsorbsi
Absorpsi glukosa(membranperitoneum)
CAPD 60% glukosa yang diabsorpsi Setiap gram glukosa 3.4 kcal
Dialysate(dextrose
Gram ofdextrose/L
Kcal/L fromdextrose
Kcal/L with CAPD(dextroseconcentration)
dextrose/L dextrose
1.5 %
2.5%
4.25%
15
25
42.5
51
85
144.5
31
51
86.7
Pasien CAPD menggunakan 4 L of 1.5%dialysate and 4 L of 4.25% dialysate perhari
4 L 1.5% = 124 kcal (31 kcal/L x 4 L) 4 L 1.5% = 124 kcal (31 kcal/L x 4 L)4 L 4.25% = 346.8 kcal (86.7 kcal/L x 4 LTotal Kcal absorbed = 470 kcal
*Periodic Nutritional ScreeningSalb, Weight, BMI, MIS, DPI, DEI
Nutritional Assessment (as indicated)Sprealb, SGA, Anthropometrics
Continuous Preventive Measures :Continuous Nutritional Counseling
Optimize RRT-Rx and Dietary Nutrient IntakeManage co-morbidites (Acidosis,DM,Inflamation,CHF,Depression)
Indication for Nutritional Interventions Despite Preventive Measure :• Poor appetite and/or poor oral intake• DPI<1,2(CKD 5D) or <0.7(CKD 3-4:DEI<30Kcal/kg/d• Unintentional weight loss >5% of IBW or EDW over mo
Algorithm for nutritional management and support in patient with CKD(Clinical Journal of the American Society of Nephrology)
• Unintentional weight loss >5% of IBW or EDW over mo• Salb < 3,8 g/dl or Sprealb < 28 mg/dl• Worsening Nutritional Markers Over Time• SGA in PEW range
Salb > 3,8 ; Sprealb >28Weight or LBM gain
Start CKD-Specific Oral Nutritional Supplementation :•CKD 3-4 : DPI target of > 0.8g/kg (±AA/KA or ONS)•CKD 5D : DPI target >1.2g/kg/d (ONS at home or during dialysistreatment ; in-centre meals)
No Improvementor Deterioration
Maintenance Nutritional TherapyGoals :
• Salb > 4.0g/dl• Sprealb > 30 mg/dl• DPI > 1,2 (CKD-5D) & >0.7 g/kg/d
(CKD 3-4)• DEI 30-35 Kcal/kg/d
Intensified Therapy :• Dialysis prescription alterations• Increase quantity of oral therapy• Tube, feeding or PEG if indicated• Parenteral interventions :
• IDPN (esp.if salts <3.0g/dl)• TPN
Adjuvant Therapies :• Anabolic hormones
• Androgen,GH• Appetite stimulants• Antiinflamatory interventions
• Omega 3; IL-1ra• Exercise (as tolerated)
Interventions to prevent and/or treat PEW in CKD patients
(1) Pre-dialysis patients
- Optimal dietary protein and calorie intake
- Optimal timing for initiation of dialysis, before onset of indices of malnutrition
(2) Dialysis patients
- Appropriate amount of dietary protein intake (> 1.2 g/kg/day) along with nutritionalcounseling to encourage increased intake
- Optimal dose of dialysis (Kt/V > 1.4 or URR > 65%)
- Use of biocompatible dialysis membranes- Use of biocompatible dialysis membranes
- Enteral or intradialytic parenteral nutritional supplements (hemodialysis) and amino aciddialysate (peritoneal dialysis) if oral intake is not sufficient
- Growth factors (experimental):
• Recombinant human growth hormone
• Recombinant human insulin-like growth factor-I
(3) Transplant patients:
- Appropriate amount of dietary protein intake
- Avoidance of excessive use of immunosuppressives
- Early reinitiation of dialytic therapy with proper steroid tapering in patients with chronic rejection
Kidney Int. 1996;50:343-357
Frequency of screening for PEW in CKD
Weekly for inpatient
2-3 mo for outpetients with eGFR < 20but not on dialysis
Summary of Clinical Practice Guideline for Nutrition in CKD
Within one mo of commencement ofdialysis then 6-8 weeks later
4-6 mo for stable haemodialysis patients
4-6 mo for stable peritoneal dialysispatients
Nephron Clin Pract 2011; 118 (suppl):c153-c164